Cancer test firms Pacific Edge, TruScreen give market some cheer

Paul McBeth
Tue, 16 Oct 2018

By Paul McBeth Oct. 16 (BusinessDesk) - Cancer test makers Pacific Edge and TruScreen both gave investors something to cheer about as they made headway in their respective markets.  The Cxbladder manufacturer Pacific Edge shares surged by a third after successive announcements on breaking into the North America health bureaucracy, although the stock came off the boil today, down 3.9 percent to 37 cents. John Hopkins Medicine is evaluating the bladder cancer test and the Centers for Medicare and Medicaid Services have set the preliminary r...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Opinion
Putin's war is a challenge to global corporate conscience
David Brain | Sat, 28 May 2022

Global businesses with strong retail brands appear the most likely to stop doing business in Russia altogether, but there are holdouts.

On the Money
ON THE MONEY: Greg Foran, Straker and Ryman Healthcare
Victoria Young | Sat, 28 May 2022

OTM this week: The PM’s US tour, Grant Robertson’s golden rules, Greg Foran and more.

Politics
Sydney firm to build NZ Police’s arms information system
Ava Bradley | Fri, 27 May 2022

The company’s software will provide a secure digital database of all firearms transactions and legally owned firearms in NZ and is estimated to bring in $13 million for the ASX-listed company.

Partner content
Small business lessons for attracting and retaining staff

Employers battling through the ‘Great Resignation’ are now faced with the ‘Great Brain Drain’.

Partner content
People leaders are key to wellbeing but still need help

One in three people say they have experienced an issue with an unsupportive manager